ACTRN12606000192583已完成2 期
A randomised, double blind, placebo controlled, Phase IIa study of the safety of R-flurbiprofen administered as a topical gel to patients with a history of non-melanoma skin cancer
PharmaQest Pty Ltd0 个研究点目标入组 40 人开始时间: 2006年5月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Must have had at least one non-melanoma skin cancer in the past 5 years.
排除标准
- •Any significant medical disorder;Current use of NSAIDs (and unwilling to cease use).
研究者
相似试验
进行中（未招募）
不适用
Fulvestrant +/- vandetanib in advanced aromatase inhibitor resistant breast cancer.Metastatic breast cancer that has become resistant to aromatase inhibitor therapyEUCTR2014-001208-23-GBVelindre NHS Trust
进行中（未招募）
1 期
A comparison of continuous Avastin treatment or placebo in addition to lomustine followed by standard treatment for worsening brain cancerMedDRA version: 19.0 Level: PT Classification code 10018336 Term: Glioblastoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)GlioblastomaEUCTR2012-003138-17-GBF. Hoffmann-La Roche Ltd296
进行中（未招募）
1 期
Clinical study evaluating if the patient is better and lives longer if bevacizumab is continued to be added to the standard treatment for worsening brain cancerMedDRA version: 19.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)GlioblastomaEUCTR2012-003138-17-SEF. Hoffmann-La Roche Ltd300
进行中（未招募）
1 期
A comparison of continuous Avastin treatment or placebo in addition to lomustine followed by standard treatment for worsening brain cancerMedDRA version: 18.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)GlioblastomaEUCTR2012-003138-17-LVF. Hoffmann-La Roche Ltd300
进行中（未招募）
1 期
A comparison of continuous Avastin treatment or placebo in addition to lomustine followed by standard treatment for worsening brain cancerGlioblastomaEUCTR2012-003138-17-ATF. Hoffmann-La Roche Ltd300